RxDoctor Payments Data

Tenley Lawton, MD

Plastic Surgery · Irvine, CANPI 1689689044

Payments from drug & device makers

What this record shows

This record is dominated by gifts: $26,517 of the $38,838 with a category attached, or 68.3%. AbbVie accounts for 88.6% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2019 at $27,085 and has fallen 82.2% since, to $4,824 in 2025. Among plastic surgery clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$38,838in general payments, 2019–2025

Across 211 payments — averaging $184.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$34K
  • Motiva USA, LLC$3K
  • Integra Lifesciences Corporation$686
  • Apyx Medical Corporation$136
  • Innovation Technologies Inc$119
  • TELA Bio, Inc.$82
  • plus $130 from 3 others
$32,364in research payments, 2019–2025

Across 9 payments — averaging $3595.94 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AbbVie$32K

What the payments were for

  • Consulting fees$1,8325%
  • Speaking & faculty fees$5,02313%
  • Travel & lodging$5341%
  • Food & beverage$4,28211%
  • Gifts$26,51768%
  • Other$6522%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$38,838 in reported general payments places this provider in the 90th percentile of 780 plastic surgery providers in California.

See all plastic surgery providers in California

Medicare billing

Part B allowed, 2024
$23,868
Medicare patients
32
Services billed
57

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen28$338
Ondansetron Hcl31$183
Cephalexin16$177

Paid to pharmacies, not to this prescriber.

Other plastic surgery in Irvine

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →